The impacts and service responses to Injecting Synthetic Cathinones and Novel Synthetic Opioids amongst marginalised drug using populations – a scoping review by Scheibein, F et al.
 
Scheibein, F, Wells, JSG, Henriques, S and Van Hout, MC
 The impacts and service responses to Injecting Synthetic Cathinones and 




LJMU has developed LJMU Research Online for users to access the research output of the 
University more effectively. Copyright © and Moral Rights for the papers on this site are retained by 
the individual authors and/or other copyright owners. Users may download and/or print one copy of 
any article(s) in LJMU Research Online to facilitate their private study or for non-commercial research. 
You may not engage in further distribution of the material or use it for any profit-making activities or 
any commercial gain.
The version presented here may differ from the published version or from the version of the record. 
Please see the repository URL above for details on accessing the published version and note that 
access may require a subscription. 
For more information please contact researchonline@ljmu.ac.uk
http://researchonline.ljmu.ac.uk/
Citation (please note it is advisable to refer to the publisher’s version if you 
intend to cite from this work) 
Scheibein, F, Wells, JSG, Henriques, S and Van Hout, MC (2019) The 
impacts and service responses to Injecting Synthetic Cathinones and Novel 
Synthetic Opioids amongst marginalised drug using populations – a 




The impacts and service responses to Injecting Synthetic Cathinones and Novel Synthetic 
Opioids amongst marginalised drug using populations – a scoping review 




aSchool of Health Science, Waterford Institute of Technology, Waterford, Ireland; b School of 
Health Science, Waterford Institute of Technology, Waterford, Ireland; c University Institute of 
Lisbon (ISCTE-IUL) / Centro de Investigação e Estudos de Sociologia (CIES-IUL) and 




Corresponding author: Florian Scheibein (fscheibein@gmail.com)  
 





A growing body of literature reports on the injection of synthetic cathinones (SC) 
and novel synthetic opioids (NSO) in marginalised drug using (MDU) populations. 
This review seeks to establish what is known about the injection of SCs and NSOs 
impacts on MDUs. 
 
Method 
A six-stage iterative scoping literature review was conducted in relation to SCs, 
NSOs, MDU impacts and service responses. Searches were conducted through 
Pubmed™ and Google Scholar™.   
 
Results  
Two Thousand and Ninety-Nine search items were retrieved. After duplicates were 
removed (n=880), articles were screened for injecting drug use by MDUs leading to 
the removal of a further 1102 articles. Three articles were identified through a hand 
search, yielding a total of 22 articles for appraisal.  
 
Conclusions 
SC injection has largely dissipated due to service and policy responses and changes 
in the drug market. Responses to NSO have been less effective, with extensive use 
and opioid overdosing due to contamination and adulteration within the illicit drug 
market. These impacts have stimulated innovative responses such as fentanyl test 
strips and housing-based consumption sites. The evidence for their effectiveness is 
not established. In this context, the underlying environmental and structural factors 
shaping the risk of these populations should be addressed.  
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Marginalised drug users (MDUs) such as some people who are homeless, have criminal histories 
and/or mental health issues are known to inject synthetic cathinones and novel synthetic opioids 
(EMCDDA, 2017a; Giese et al., 2015; Hope et al., 2016; Tarján et al., 2015, 2017). It appears that 
these populations experience disproportionate injecting-related harms compared to other groups 
(Van Hout et al., 2018). The injection of synthetic cathinones such as mephedrone, alpha-PVP and 
pentedrone are linked with HIV outbreaks amongst MDUs in Ireland, Israel and Hungary (Giese 
et al., 2015; Katchman et al., 2017; Tarján et al., 2017). Northern American MDUs are 
experiencing overdoses linked to the adulteration of market supplies with novel synthetic opioids 
such as fentanyl, U-47770 and AH7921 (Wallace et al., 2019). Knowledge deficits exist around 
the impacts of this injecting in relation to the efficacy of service responses for MDU populations. 
This paper reviews the current literature on synthetic cathinones and novel synthetic opioids with 
the aim to scope what is currently known around impacts in order to identify what may be needed 
in terms of effective policy development and service responses. 
Methods 
Scoping reviews are a  method of exploring an issue broadly (Pham et al., 2014) as they allow for 
the mapping of all the available extant literature (including grey literature) of previously under-
researched topics (Arksey & O’Malley, 2005). This study used an iterative six step process 
developed by Levac, Colquhoun, & O’Brien, (2010). These steps consist of: (1) identifying the 
research question; (2) identifying relevant studies; (3) study selection; (4) charting the data, (5) 




  The scoping review commenced with posing the research question “What is known about the 
injecting use of synthetic cathinones (SCs) and novel synthetic opioids (NSOs) by MDUs in 
relation to impacts (practices, health and social harms) and service responses.” MDUs were 
defined as a population with a high prevalence of  homelessness, criminal histories and/or mental 
health issues (EMCDDA, 2017).  
  An exploratory online search was conducted in the National Documentation Centre for Drugs 
and Library of Ireland (a comprehensive catalogue of international literature of drug pertinent 
research papers, news and policy documents). This was supplemented by a review of the SCs and 
NSOs as posted by the European Monitoring Centre on Drugs and Drug Addiction (EMCDDA) 
website. 
  This initial search led to the development and refining of search terms (Table 1). Subsequent 
comprehensive searches of Pubmed™ and Google Scholar™ were performed utilising these 
search terms. The database searches were restricted to ‘Humans’, publications in the English 
language and a publication timeframe of between 2009 and 2019 (Table 1-4). Reference lists in 
articles were also reviewed for undiscovered extant literature, including grey literature. 
  Eligibility for inclusion criteria centred on whether studies considered injecting SCs or NSOs by 
MDUs. The title and abstract of each citation were screened for relevance to these parameters 
where doubt remained team discussions took place (Levac, Colquhoun, & O’Brien, 2010). 
  Two Thousand and Ninety-Ninety search items were retrieved through the database search. After 
duplicates were removed (n=880) articles were screened for injecting drug use by MDUs leading 
to the removal of a further 1102 articles. A further 3 articles were identified through a hand search, 
yielding a total of 22 articles for critical appraisal (Figure 1). 
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  Included articles were initially recorded in relation to author; year of publication; study location; 
methodology and key findings broke down relevant information thematically (Richie and Spencer, 
(1994) (See: Table 5). Articles were thematically organised into ‘Profile as related to use’, 
‘Practices and Behaviours associated with injecting’, ‘Social Impacts’, ‘Health Impacts’ and 
‘Service Responses’..   
As a final stage, the review was forwarded to an Expert International Advisory Group of NPS 
injecting researchers to identify other pertinent and previously undiscovered papers for inclusion. 
Profile as related to use 
In Ireland, Van Hout & Bingham (2012) report that poor quality of cocaine and ecstasy; positive 
peer reports and the ready availability of SCs in ‘head shops’ contributes to the decision of MDUs 
to initiate SC injection.  Research in Hungary (Tarjan et al., 2017) and Israel (Katchnman et al., 
2017) found that market shifts preceded a shift towards SC injecting. Csak (2016) reports that the 
phenomenon of SC injecting is one predominantly associated with poverty and marginalisation in 
Hungary.  
  NSO studies report their increased prevalence, specifically fentanyl (NSO) and related analogues, 
in the context of endemic adulteration of illicit drug market supplies with such substances. 
Estimated fentanyl exposure ranged from 56% in Baltimore (Park et al., 2019) to 56.3% in Cabell 
County (Allen et al., 2019)in the United States. Two studies report a link between homelessness 
and fentanyl exposure (Krieger et al., 2018; Macmadu et al., 2017). 
  Studies report a high prevalence of homelessness in MDUs reporting SC injecting. Prevalence 
ranges from 18% in the United Kingdom (Hope et al., 2016) to approximately 63-75% in Ireland 
(Van Hout and Bingham, 2012, O’Reilly, 2011). Other studies indicate prevalence rates of 57% in 
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Hungary (Tarjan et al., 2017), 59.5% in Israel (Katchman et al., 2015) and 66.3% in Czechia 
(Belackova et al., 2017). 
  High levels of homelessness are also reported in populations exposed to NSOs. Prevalence ranged 
from 56.9% to 66.1% in Canada (Hyska et al.,2016; Kennedy et al., 2019; Wallace et al., 2018); 
and 30.4% to 57.1% (Peiper et al., 2018; Latkin et al., 2019; Park et al., 2018; Hunter et al., 2018; 
Allen et al., 2019) in America. 
  One Irish study examined SC injecting amongst related prison populations. Drummond et al. 
(2014) found widespread SC injecting amongst prisoner PWID, particularly incarcerated women. 
In Hungary, 65% of a population attending a needle and syringe program (NSP) reported a history 
of imprisonment and most of this population reported injecting SCs (Tarján et al., 2017).  
  Adulteration of other drugs with fentanyl (NSO) was reported as common place in Canadian 
prisons and there was a concern that fentanyl was being used to attack and murder people(Bucerius 
& Haggerty, 2019). Bucerius and Haggerty (2019) reported that the emergence of NSOs led to 
several changes in Western Canadian prisons. Prisoners reported that there were now more 
frequent overdoses. However, prisoners also reported that prisons were a relatively safe 
environment in which to use drugs.   
   Four out of five prisoners with dual diagnosis in Delware County, Ohio, USA, tested positive 
for exposure to acetylfentanyl (Miller et al., 2018). In other NSO studies, populations exposed to 
fentanyl reported criminal history involving arrest and or imprisonment ranging from 30.6% in  






Practices and Behaviours associated with injecting  
SCs have been associated with people injecting several times per day (Tarján et al., 2017; Van 
Hout & Bingham, 2012); sharing needles and equipment with others (ibid.); poor injection 
practices (Van Hout & Bingham, 2012); street and communal injecting (ibid.); and polydrug use 
(Belackova et al., 2017; Hope et al., 2016).  
SCs can be associated with differing injecting practices. For example, in Hungary people who 
inject SCs were found to be more likely to share syringes (52.9%:51; 14.6%:41; 29.2%:65) and 
equipment (64%: 51; 24.4%:41; 38.5%:65) compared to people who injected amphetamines or 
opioids (p=<0.05). People who used SCs were also found, in this study, to inject more frequently 
on a daily basis and more likely to reuse equipment (Tarján et al., 2017).  
  In the UK, Hope et al. (2016) reported that people who injected mephedrone (an SC), when 
compared to groups injecting other substances, were more likely to report sharing (28%; n=46 vs. 
14%; n=272; p <0.001) and receptively sharing equipment (59%; n =96 vs 46%; n = 864; p = 
0.001). People who reported injecting mephedrone were also more likely to report injecting other 
drugs (63% (n = 102) vs 15% (n = 289); p < 0.001). Similarly, Belackova et al., (2017) reports the 
repeated use of SCs being linked to co-occuring use of stimulants and opioids (AOR=4.3; 
AOR=2.4) in Czechia.  
  Studies report the unnecessary use of citric acid as a as a dissolving agent for SC injection, mixing 
in barrels and groin injecting ( Rácz et al., 2016; Van Hout & Bingham, 2012). MDUs are reported 
frequently to inject at or near the point-of-sale and to engage in communal injecting - often in 
unsanitary environments such as on the street or in toilets ( Rácz et al., 2016; Van Hout & 
Bingham, 2012).  
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  In the United States, fentanyl may have started emerging in the drug supply as early as 2013 and 
fentanyl-containing samples were thought to be distinguishable by a sweet taste and white 
color.(Ciccarone, Ondocsin, & Mars, 2017). Latkin et al., (2019) state that 56% of a population in 
Baltimore, USA reported exposure to fentanyl contamination in “all” or “almost all” heroin. 
Seventy-five percent of this sample worried about their friends overdosing and 66% reported 
receiving naloxone (or a prescription for it). However, only 13% reported having the overdose 
medication naloxone available “often” or “always” (ibid.).  
  McKnight & Jarlais (2018) study of a MDUs in New York, USA reported several behaviours in 
on the part of MDUs who assumed they has used NSOs. These included taking tester shots; finding 
consistent dealers; carrying naloxone; using with others; reducing use and using fentanyl-test strips 
(which test for the presence of fentantils). McKnight & Jarlais (2018) note that stigma, poverty 
and homelessness often prevent the consistent application of these methods and that homelessness 
is a significant factor in public injecting. 
Social Impacts 
Fentanyl may be used for facilitating sexual assaults and people may inject in public places to 
avoid such assaults (Boyd et al., 2018). On the street, people are more likely to be harassed, have 
their injecting equipment destroyed or confiscated (Boyd et al., 2018; Hunter et al., 2018). 
Injecting of SCs and NSOs can also lead to homelessness. For example, O’Reilly, McAuliffe, & 








Tarján et al (2017) found the highest hepatitis C (HCV) prevalence among people who inject SCs 
when compared to those injecting classical drugs like heroin (38.6% versus overall of 23.2%). 
Within the SCs group, HCV prevalence was highest in those reported to inject pentedrone (52.4%) 
and methylenedioxypyrovalerone – MDVP (45%), which corresponds to the groups most likely to 
report sharing of equipment, for both substances. Additionally, those reporting pentedrone 
injection were more likely to report reusing equipment. HCV prevalence reportedly doubled 42%–
71% between 2011-2014 during the time period where SC injection increased dramatically (ibid). 
HCV prevalence increased 7-fold (12%-76%) in young people who reported injecting SCs (aged 
<25) and doubled in people who had recently started injecting SCs (<2 years) (op cit).  Hope et al 
(2016)  found there was an association between a MDU population reporting injecting mephedrone 
and HCV prevalence.   
  Hope et al (2016) found that people who inject mephedrone were three times more likely to have 
HIV antibodies. Giese et al (2016) found an association with the injection of the SC ‘Snow Blow’ 
and newly acquired HIV infection.  Katchman et al., (2016) found that a rapid increase in the rate 
of HIV detections in Tel Aviv, Israel was related to a reported rise in the transitioning of MDUs 
to SC injection.  
  In a cross-sectional survey of 203 people attending a NSP in Baltimore, USA (Park et al., 2018), 
independent correlates of nonfatal overdoses included perceiving fentanyl in drugs more than half 
the time and homelessness. In a questionnaire administered to 199 MDUs, Wallace et al. (2018) 
reports that almost half of those recently reporting overdosing had overdosed outdoors/on the 
street; over a quarter had reported overdosing in a shelter or ‘other service’ whilst another quarter 




The adoption of high risk injecting behaviours and an increase in HCV and HIV infection 
associated with SC injecting in Hungary (Tarján et al., 2017) occurred during a period of dramatic 
reductions in funding and distribution of syringes (75% decrease) between 2011-2015. This also 
included the closure of the Bluepoint service (Hungary’s largest NSP). These resource reductions 
likely exacerbated both these high risk behaviours and consequent health impacts. 
  SC injecting-related HIV outbreaks in Ireland and Israel were contained through the use of 
bespoke tailored interventions which addressed the specific needs of these populations (Giese et 
al., 2015; Katchman et al., 2017). In Ireland, this took the form of engaging with HIV positive 
people who inject drugs (PWID); offering HIV testing; raising awareness amongst PWID and 
clinicians of the harms associated with the injection of SCs and the need to engage with methadone 
and treatment services. There was also enhanced contact tracing and case finding systems 
accompanied by improved access to NSPs by improving outreach services (Giese et al., 2015). In 
Israel, a similar multi-faceted approach was utilised with educational activities; increasing syringe 
exchange supplies; active screening and early initiation into antiretroviral programs; and referrals 
to drug withdrawal programs (Katchman et al., 2017). 
  Bucerius and Haggerty (2019) report that prisoner officers in Canada expressed worries about 
inadvertent exposure to fentanyl and procedures such as wearing protective gear were 
implemented by some officers despite the evidence of risk being low. This increased response 
times during overdose crisis management.  
  The ubiquity of fentanyl-adulteration and contamination has prompted discussion and 
implementation of several innovative harm reduction services and programs including fentanyl-
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testing strips (Krieger et al., 2018); peer witness programs and consumption sites in housing 
projects (Bardwell et al., 2018). These programs currently lack thorough evaluation.  
  Fentanyl-test strips are a simple innovation that can test for a variety of fentanyl analogues within 
a batch of a given sample. Krieger et al (2018) report that 98% of a surveyed MDU population 
trusted fentanyl test strips and that 95% would use them again. Old age, homelessness and 
witnessing an overdose were associated with an increased likelihood to report in engaging with 
drug checking services (Sherman et al., 2019). An American online survey of MDUs intending to 
use fentanyl test strips suggested that a positive result for fentanyl was associated with a five times 
higher likelihood of changing their behaviour (Peiper et al., 2018). However, 31% of the sample 
reported actively seeking out fentanyl (ibid)- some may also prefer fentanyl-heroin 
combinations(Ciccarone et al., 2017) 
  A two-tier system of drug consumption sites is operational in Canada whereby supervised 
consumption sites are federally licensed and overdose prevention sites are given rolling permission 
to continue their services (Kennedy & Coelho, 2019). In this context, peer workers who have 
experience of drug use are permitted to work in overdose prevention sites but not in the federally 
licenced consumption sites and they are not paid for these positions. Kennedy & Coelho (2019) 
report that MDU populations may be more likely to engage with overdose prevention sites as 
service users report that they prefer attending services staffed by peer workers. However, a 
significant issue arises in that the work can be extremely demanding and there is no payment for 
such workers and/or other benefits associated with normal employment (ibid.) 
  Homelessness appears to be linked to fentanyl exposure and overdoses (Park et al., 2018) and 
people who inject fentanyl report experiencing overdoses in homeless services (Wallace, Barber, 
& Pauly, 2018). Bardwell et al., (2018) suggests that safer consumption sites should be considered 
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across homeless services; including in the form of peer witness programs where peers may 




The injection of SCs and NSOs is associated with significant differences in terms of profile as 
related to use; injecting practices and behaviours; health impacts; social impacts and service 
responses. Injection of SCs and NSOs are negatively associated with underlying issues of 
marginalised drug use such as homelessness, stigma, criminalisation and a lack of effective service 
responses.  
  SCs have in some countries largely replaced traditional drugs as a result of a variety of forces 
including the decreased quality and purity of traditional substances (Tarjan et al., 2017). They 
appear to be associated with several drug-specific harms (such as the corrosive nature of the 
substances) and drug-related harms such as increased frequency of injection and sharing needles 
and equipment. Such harms were exasperated in some jurisdictions due to decreased availability 
of classical harm reduction services (such as the shutting down of NSPs in Hungary) and the lack 
of drug-specific interventions.  In contrast, Irish and Israeli service and policy responses appear to 
be largely successful in substantially reducing and/or eliminating these substances and their related 
harms within their respective jurisdictions (Giese et al., 2015; Katchman et al., 2016).  
  NSOs have dispersed into traditional drug markets with incredibly high levels of exposure 
reported (Park et al., 2019; Allen et al., 2019). Unlike SCs, which were largely associated with 
now largely contained HIV outbreaks, fentanyl and related analogues seem to be associated with 
a growing opioid overdose epidemic in the USA and Canada. This epidemic is driving a need for 
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new innovations such as fentanyl-test strips, the expansion of peer-based approaches and 
consumption sites in housing programs. 
Limitations 
This review only considered SCs and NSOs injection in MDUs in a ten-year time frame (2009-
2019). Our definition of MDU was high threshold and excluded a significant number of studies 
such as those pertaining to other marginalised populations such as Indigenous people and migrants. 
Similarly, we included a non-extensive list of novel psychoactive substances which may be 
injected, namely, a selection of SCs and NSOs.  
 
Conclusion 
SC injection is a phenomenon that has largely dissipated in many parts of the world due to service 
and policy responses and changes in the drug market. However, NSOs continue to remain a 
substantial and sizeable issue with significant human and social cost. Innovative solutions such as 
fentanyl test strips, housing-based consumption sites and expanded peer programs programs 
should be piloted and evaluated. The link between homelessness and the adoption of high risk 
behaviours such as street injection should prompt policymakers to make greater investment in 
addressing these specific issues.   
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Table 1: Search strategy Google Scholar-Cathinones 
 
1. cathinone* (7360) 
2. inject OR injecting OR injection OR PWID 
(1,380,000) 
3. marginalised OR marginalized OR vulnerable 
OR homeless OR prisoner OR "mental health" 
(78,100) 
4. 1 AND 2 AND 3 (1330*) (*1000 retrieved) 
 
Table 2: Search Strategy PubMed- Cathinones  
 
1. Cathinone (390) 
2. methcathinone OR ephedrone (82) 
3. N,N-Dimethylcathinone OR metamfepramone 
(2) 
4. Buphedrone (7) 
5. 4-Methyl-N-ethylcathinone (9) 
6. Mephedrone OR 4-MMC OR M-CAT (326) 
7. Amfepramone (39) 
8. Bupropion (1735) 
9. Methylone OR βk-MDMA (111) 
10. Ethylone OR βk-MDEA (22) 
11. Butylone OR βk-MBDB (33) 
12. Methedrone OR βk-PMMA (25) 
13. Flephedrone OR 4-FMC (24) 
14. 3-Fluoromethcathinone OR 3-FMC (12) 
15. α-Pyrrolidinopropiophenone OR PPP (1288) 
16. 4-Methyl-α-pyrrolidinopropiophenone OR 
MPPP (10) 
17. 4-methoxy-α-pyrrolidinopropiophenone OR 
MOPPP (0) 
18. 4-Methyl-α-pyrrolidino-hexanophenon OR 
MPHP (8) 
19. Pyrovalerone (31) 





pyrrolidinopropiophenone OR MDPPP (5) 
23. 3,4-Methylenedioxypyrovalerone OR MDPV 
(173) 
24. N-Ethylcathinone (13) 
25. Search 1-25 
26. inject OR injecting OR injection OR PWID 
(102490) 
27. marginalised OR marginalized OR vulnerable 
OR homeless OR prisoner OR "mental health 
(148490) 



























Table 3: Search Strategy Google Scholar- Novel 
Synthetic Opioids 
1. fentanyl OR fentanils (156,000) 
2. U-47700 (539) 
3. AH-7921 (412) 
4. MT-45 (1220) 
5. inject OR injecting OR injection OR 
PWID 1,380,000 
6. marginalised OR marginalized OR vulnerable 
OR homeless OR prisoner OR "mental 
health" 78,100 
7. 1-4 AND 5 AND 6 (8,630*) (*1000 retrieved) 
 
Table 4: Search Strategy PubMed- Cathinones 










carboxylate” OR carfentanil (113) 
5. “3,4-dichloro-N-{[1-
(dimethylamino)cyclohexyl]methyl}benzamide” 
OR AH-7921 (21) 
6. “1-cyclohexyl-4-(1, 2-diphenylethyl)piperazine)” 
OR MT-45 (26) 
7. “N-(1-phenethylpiperidin-4-yl)-N-
phenylacrylamide” OR acryloylfentanyl (6) 
8. “N-phenyl-N-[1-(2-phenylethyl)piperidin-4-
yl]furan-2-carboxamide” OR furanylfentanyl 
(15)  
9. U-47700 (43) 
10.  1 -9 (5349) 
11. inject OR injecting OR injection OR PWID 
(102490) 
12. marginalised OR marginalized OR vulnerable OR 
homeless OR prisoner OR "mental health" 
(148490) 












































2099 Papers retrieved Duplicates removed: 
880 
 
1219 Title and 
Abstracts screened for 
relevance 
1102 papers removed  
117 papers retrieved Non marginalised drug 
use* studies excluded: 
95 
Papers included from 
hand search: 3 
 Studies meeting 







Table 5: Summary of Results 
Study (Year) City, Country Method Key findings 




Capture and recapture; 
survey 
56.3% reported injecting 
fentanyl; 57.1% reported being 
homeless; 30.6% reported 
being arrested in last 6months;  









Severity of dependence 
symptom scores and risky 
injecting practices associated 
with repeated synthethic 
cathinone use in single-
predictor models. Repeated use 
was associated with 
homelessness (AOR = 3.2), co-
occurring use of stimulants and 
opioids (AOR = 4.3), and use of 
cannabis (AOR = 2.4) in the 
past month. 
 




Survey Participants reporting being 
homeless in the last six months; 
having accidentally overdosed; 
having used heroin; having 
used fentanyl non-medically; 
and typically using prescription 
opioids alone were more likely 
to report that they would use a 
supervised injection facility 
(Bardwell, Boyd, 




Commentary Need to consider facilitating 
drug consumption sites within 
homeless services 






65% homeless in the last year 
women in Canada. Use of 
fentanyl to facilitate sexual 
assaults.  






Ethnographic research Fentanyl started emerging in 
2013; distinguish with taste 
(sweet) and colour (white); 
admixtures of fentanyl and 
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heroin can be considered 
helpful 
(Csak, 2016) Hungary Questionaires, 
surveys 
Marginalised populations are 
particulary affected by 
cathinone injecting. Lack of 
knowledge of available 
services. Use driven by a desire 
to escape “reality, problems, 
pain, poverty and segregation”. 
Services should include harm 
reduction, outreach and efforts 
to enhance employment 
prospects. 
 
(Giese et al., 
2015) 
Dublin, Ireland Case series HIV outbreak linked to the 
injection of synthetic cathinone 
alpha-PVP amongst a 
population with high levels of 
homelessness and criminal 
justice involvement. 
(Hope et al., 
2016b) 





18% homeless. 72% had ever 
been imprisoned. 8% had 
injected mephedrone. In 
multivariate analysis, those 
injecting mephedrone were 
found to be younger, less likely 
to have injected opiates and 
more likely to have injected 
cocaine or amphetatmines and 
used a NSP or sexual health 
service. Those injecting 
mephedrone more often had 
hepatitis C antibodies, human 
immunodeficiency virus and 
overdosed  
 






58% reported injecting fentanyl 
more than half the time; 33% 
reported being homeless; 29% 
had been arrested or 
incarcerated in last 12 months; 
48% reported having their 
syringes confiscated or 
discarded by the police; PWID 
who injected in public places 
were more likely to be arrested, 
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to report overdosing and to 
share injecting equipment. 
(Hyshka et al., 
2016) 
Alberta, Canada Survey 12.5% reported injecting 
fentanyl in last 6 months; 
56.9% reported being in 
unstable accommodation; peer 
worker involvement may be 
able to increase engagement at 
overdose prevention sites 
(Katchman et al., 
2017) 
Tel Aviv, Israel Case control 59.5% homeless. Injection of 
cathinone led to HIV outbreak. 
Interventions helped reduce 
effect. 







65% homeless; 86% unstably 
housed; peer involvement may 
increase engagement with 
overdose prevention sites  






98% reported confidence in 
using fentanyl test strips; 95% 
said they would use them again; 
a positive result was associated 
with homelessness, older age, 
injecting drug use, ever 
witnessing an overdose, and 
concern over overdose and 
drugs adulteration with 
fentanyl 




Interviews 52.5% homeless; 66.% injected 
in last 6 months; majority 
believed that they were 
exposed to fentanyl from some 
to all of the time 




Questionaire 11% reported exposure to 
fentanyl contaminated heroin; 
47.2 ever detained in 
jail/prison; 54.3% ever 
homeless. Those in contact 
with fentanyl-contaminated 
heroin were more likely to be 
homeless and have tested 
positive for HCV (p= <0.05), 
regular heroin 
and cocaine use. 





Focus groups 4/5 inmates with dual diagnosis 








In-depth interviews Study discusses adaptions in 
response to fentanyl such as 
taking test doses, using fentanyl 
test strips, reducing use, using 
with others and carrying 
naloxone. Notes stigma, 
poverty and homelessness as 
barriers to implementation of 
such behaviours 




37% homeless; 53% perceived 
fentanyl to be present in their 
drugs half or all the time; non 
fatal overdoses to perceiving 
fentanyl in drug more than half 
the time in last twelve months; 
homelessness 
Peiper et al., 
(2018) 
Online survey Greensboro, United 
States 
30.4% unstable housing; 56% 
reported a positive result; those 
reporting a positive result were 
five times more likely to 
change their behaviour; 31% 
reported wanting fentanyl when 
they purchased their drugs 
Sherman et al., 
(2019) 




Island, United States 
Factors independently 
associated with intent to use 
drug checking included: older 
age; homelessness; being non-
white; witnessing ≥1 fatal 
overdose ; and suspected recent 
fentanyl exposure. 




Victoria, Canada 66.1% homeless reporting 
recent non-fatal overdose; 
28.6% criminal history; almost 
half reported their latest 
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were positively associated with 
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